Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-511-5p (miR-511-5p) is a highly conserved small non-coding RNA that functions as a critical post-transcriptional regulator of gene expression (PMID: 22504410). It is uniquely encoded within the fifth intron of the MRC1 gene, which encodes the mannose receptor (CD206), and is predominantly expressed in M2-polarized macrophages where it modulates the inflammatory phenotype (PMID: 24613947). miR-511-5p exerts its biological effects by binding to the 3' untranslated regions (UTRs) of specific target mRNAs, such as Toll-like receptor 4 (TLR4) and Tribbles pseudokinase 2 (TRIB2), leading to their degradation or translational inhibition (PMID: 24613947, PMID: 28656231). In oncology, miR-511-5p typically acts as a tumor suppressor, with downregulated levels observed in colorectal cancer, glioblastoma, and hepatocellular carcinoma, where its restoration inhibits cell proliferation and migration (PMID: 26918253, PMID: 31233143). Conversely, its role in asthma involves the negative regulation of TLR4, suggesting that its expression levels can influence airway hyperresponsiveness and inflammation (PMID: 24613947). Therapeutic development targeting miR-511-5p involves the use of synthetic miRNA mimics to enhance its tumor-suppressive activity or antagomirs to modulate immune responses in inflammatory diseases. As a potential biomarker, its expression profile in tissue and biofluids is being investigated for diagnostic and prognostic utility in various malignancies and chronic inflammatory conditions.
Post-transcriptional gene silencing via 3' UTR binding, mRNA degradation, and translational inhibition (PMID: 22504410).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-511-5p (miR-511-5p) (miR-511-5p).